Global Blood Culture Tests Market is Expected to Reach USD 3989 Million by 2025

The global blood culture tests market was valued at around USD 2,133 million in 2018 and is expected to reach approximately USD 3,989 million by 2025, at a CAGR of around 10.2 percent between 2019 and 2025. Blood culture is used to identify infections in the blood. It is the microbiological culture of blood, which is useful to identify infections spreading through one’s bloodstream. Globally, bloodstream infections (BSI) are one of the leading causes of morbidity and mortality. Blood culture plays a vital role in the diagnosis of various infections, such as bacterial, mycobacterial, and fungal. The techniques used in bloodstream infection automated methods and conventional/manual methods are used by healthcare professionals to identify the contamination in the bloodstream.

The rising frequency of bloodstream infections, increasing geriatric population globally, and growing demand for blood diagnostic tests will boost the global blood culture tests market in the future. Moreover, rising research and development activities by many healthcare companies to develop advanced testing products including software, consumables, and instruments is anticipated to further drive the global blood culture tests market over the estimated timeline. The increasing investment by major healthcare players in R&D for the development of new products is also anticipated to support the blood culture market. For instance, in 2016, a prominent vendor in healthcare, Becton, Dickinson, and Company, invested USD 1,430 million for its R&D.

The global blood culture tests market is segmented based on technology, products & services, application, end-user, and method. By technology, the global blood culture tests market is segmented into culture-based technology, proteomic technology, and molecular technology. By product and services, the global the blood culture tests market is segmented into instruments, consumables and software and services. The application segment includes mycobacteria, fungemia, and bacteremia. By end-user, the market is segmented into reference laboratories, hospital laboratories, academic research laboratories, and other laboratories. By method, the market is bifurcated into automated blood culture and manual/conventional blood culture.

By region, North America dominated the blood culture tests market in 2018 due to various technological advancements. There is a significantly large presence of major healthcare firms, such as Roche Diagnostics, bioMerieux SA, Becton, Dickinson, and Company, and Thermo Fisher Scientific, Inc. in the region. These firms are contributing to the blood culture tests market growth in the region. Asia Pacific is anticipated to grow at the highest rate. The European blood culture tests market is anticipated to show significant growth in the future, owing to the presence of advanced pharmaceutical industry and highly developed healthcare infrastructure especially in UK, France, Germany, etc. The Middle Eastern and African and Latin American markets are projected to demonstrate moderate growth.

Some key players of the global blood culture tests market are Becton, Dickinson and Company, bioMérieux SA, Cepheid, Inc., Roche Diagnostics, Bruker Corporation, T2 Biosystems, Thermo Fisher Scientific, Inc., Nanosphere, Inc., Beckman Coulter, and Iridica. – Zion Market Research